Brief: Fresenius Investment In Fresenius Medical Care Reduced From Approximately 25% To Approximately 20% Of Issued Share Capital
BRIEF-Fresenius Investment In Fresenius Medical Care Reduced From Approximately 25% To Approximately 20% Of Issued Share Capital Nov 12 (Reuters) - FRESENIUS SE & CO. KGAA FREn.DE:
COMPLETES SALE OF 13.4 MILLION FRESENIUS MEDICAL CARE SHARES AT €39.00 PER SHARE, RAISING APPROXIMATELY €524 MILLION
SETTLEMENT IS EXPECTED ON 16 NOVEMBER 2026
ANTICIPATED BOOK GAIN IN LOW TO MID DOUBLE-DIGIT MILLION EURO RANGE WILL BE REFLECTED IN Q4 2026 RESULTS
REMAINS SUBJECT TO A LOCK-UP ON ITS REMAINING SHARES OF 90 DAYS
PROCEEDS WILL BE USED CONSISTENTLY WITH STATED CAPITAL ALLOCATION PRIORITIES SET OUT UNDER #FUTUREFRESENIUS
FINANCIAL INVESTMENT IN FRESENIUS MEDICAL CARE REDUCES FROM APPROXIMATELY 25 PER CENT TO APPROXIMATELY 20 PER CENT OF ISSUED SHARE CAPITAL
Source text: ID:nEQ2ZX5rBa
Further company coverage: [FREn.DE]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Fresenius Medical Care AG
See all newsFMC seen down as Fresenius cuts stake to 20%
Germany's Fresenius cuts FMC stake to 20%
Brief: Fresenius Investment In Fresenius Medical Care Reduced From Approximately 25% To Approximately 20% Of Issued Share Capital
Brief: Fresenius Medical Care AG ABB Orders Below Eur 39.00 Per Share, Says Book Runner
Brief: Bookrunner Says Fresenius Medical ABB C. 13.4 Mln Shares, Books Are Closed